Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 253 | 80 | 5 |
| Full Text Views | 4 | 0 | 0 |
| PDF Downloads | 1 | 0 | 0 |
Amodiaquine and Sulfadoxine-Pyrimethamine as Treatment for Chloroquine-Resistant Plasmodium falciparum in Rwanda
Philippe Deloron
Philippe Deloron
Malaria Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia
Search for other papers by Philippe Deloron in
Current site
Google Scholar
PubMed
Search for other papers by Philippe Deloron in
Current site
Google Scholar
PubMed
John D. Sexton
John D. Sexton
Malaria Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia
Search for other papers by John D. Sexton in
Current site
Google Scholar
PubMed
Search for other papers by John D. Sexton in
Current site
Google Scholar
PubMed
Laurent Bugilimfura
Laurent Bugilimfura
Combatting Childhood Communicable Diseases Program
Search for other papers by Laurent Bugilimfura in
Current site
Google Scholar
PubMed
Search for other papers by Laurent Bugilimfura in
Current site
Google Scholar
PubMed
Célestin Sezibera
Célestin Sezibera
Ministry of Health, Kigali, Rwanda
Search for other papers by Célestin Sezibera in
Current site
Google Scholar
PubMed
Search for other papers by Célestin Sezibera in
Current site
Google Scholar
PubMed
The efficacy of amodiaquine and sulfadoxine-pyrimethamine combination as a second-line therapy for chloroquine-resistant Plasmodium falciparum infections was investigated in Rwanda in September 1986. Children ≤5 years old presenting with a P. falciparum parasitemia 14 days after treatment with chloroquine were administered either amodiaquine (25 mg/kg over 3 days, 64 patients) or sulfadoxine-pyrimethamine (as a single dose with tablets containing 500 mg of sulfadoxine and 25 mg of pyrimethamine: ¼ tablet for children under 1 year, ½ for those 1–3 years old, and 1 tablet for those 4–5 years old; 34 patients) and followed for 7 days. Seven days after starting treatment with amodiaquine, 50 (76%) children were aparasitemic. All the children who had received sulfadoxine-pyrimethamine were aparasitemic 7 days after initiation of therapy.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 253 | 80 | 5 |
| Full Text Views | 4 | 0 | 0 |
| PDF Downloads | 1 | 0 | 0 |